International Stem Cell Corp (ISCO): EBITDA
-$48.0K
Year ended 2025-12-31
-$273.0K
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$48.0K | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $138.0K | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$469.0K | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $35.0K | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$1.66M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$2.56M | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$5.44M | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$3.17M | n/m | 2020-06-01, From 2018-01-01 |
| 2017-12-31 | -$4.62M | n/m | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | -$4.52M | n/m | 2018-04-09, From 2016-01-01 |
| 2015-12-31 | -$4.09M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$8.22M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$7.08M | n/m | 2015-03-30, From 2013-01-01 |
| 2012-12-31 | -$9.34M | n/m | 2014-03-17, From 2012-01-01 |
| 2011-12-31 | -$10.86M | n/m | 2013-03-26, From 2011-01-01 |
| 2010-12-31 | -$10.17M | n/a | 2012-03-16, From 2010-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$48.0K | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$107.31M | n/m |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | -$213.75M | n/m |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | -$511.72M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | -$75.92M | n/m |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | -$34.82M | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$21.00M | n/m |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | -$370.53M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$42.17M | n/m |
Compare ISCO, PGEN, PRTA, ROIV side by side · Screen every company in Pharmaceutical Preparations ↗